Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

JAMES R. KASINGER Insider Profile

11 Followers

JAMES R. KASINGER, GC & Secretary at Crispr Therapeutics AG, holds 95.86K shares in Crispr Therapeutics AG (Ticker: CRSP).

JAMES R. KASINGER's Trading History

CRSPCrispr Therapeutics AG		Oct 15, 2026GC & SecretaryUninformative Buy53.76K$4.93M
CRSP
Insider Shares: 95.86K (0.10%)

JAMES R. KASINGER has not reported any informative transactions for CRSP, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 15, 2026Uninformative Buy$53.76K1,073$50.10―
Oct 08, 2026Uninformative Sell$119.48K1,990$60.04―
Oct 08, 2026Uninformative Buy$27.10K1,990$13.62―
Sep 24, 2026Uninformative Sell$626.39K10,400$60.23―
Sep 24, 2026Uninformative Buy$141.65K10,400$13.62―
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

JAMES R. KASINGER insider profile FAQ

What stocks does JAMES R. KASINGER hold?
JAMES R. KASINGER holds: CRSP stocks.
What was JAMES R. KASINGER’s latest transaction?
JAMES R. KASINGER’s latest transaction was an Uninformative Buy of $53.76K.
What is JAMES R. KASINGER's role in Crispr Therapeutics AG?
JAMES R. KASINGER's role in Crispr Therapeutics AG is GC & Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.